# Sonida Senior Living, Inc.: overview SNDA · NYSE · CIK 1043000 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/snda.md) · [Financials](/companies/snda/financials.md) · [Filings](/companies/snda/filings.md) · [Insiders](/companies/snda/insiders.md) Latest reported revenue: [$207.6m](/filings/0001043000-26-000032.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001043000-26-000032). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [74.8](/filings/0001043000-25-000087.md) | [91.9 d](/filings/0001043000-26-000009.md) | [91.9](/filings/0001043000-26-000020.md) | [93.5](/filings/0001043000-26-000032.md) | [98.0](/filings/0001043000-25-000087.md) | [97.7 d](/filings/0001043000-26-000009.md) | [123](/filings/0001043000-26-000020.md) | [208](/filings/0001043000-26-000032.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | [21.9%](/filings/0001043000-25-000031.md) | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(18.4%)](/filings/0001043000-25-000087.md) | [(6.0%) d](/filings/0001043000-26-000009.md) | [(13.6%)](/filings/0001043000-26-000020.md) | [(1.7%)](/filings/0001043000-26-000032.md) | [(27.4%)](/filings/0001043000-25-000087.md) | [(30.5%) d](/filings/0001043000-26-000009.md) | [(33.6%)](/filings/0001043000-26-000020.md) | [(11.8%)](/filings/0001043000-26-000032.md) | | Diluted EPS | $ per share | [(0.98)](/filings/0001043000-25-000087.md) | not reported | [(0.77)](/filings/0001043000-26-000020.md) | [(0.16)](/filings/0001043000-26-000032.md) | [(1.56)](/filings/0001043000-25-000087.md) | not reported | [(2.39)](/filings/0001043000-26-000020.md) | [(0.52)](/filings/0001043000-26-000032.md) | | Free cash flow | $m | [(5.1) d](/filings/0001043000-25-000087.md) | [(10.4) d](/filings/0001043000-26-000009.md) | [(4.5)](/filings/0001043000-26-000020.md) | [1.9 d](/filings/0001043000-26-000032.md) | [3.0 d](/filings/0001043000-25-000087.md) | [(9.3) d](/filings/0001043000-26-000009.md) | [(42.6)](/filings/0001043000-26-000020.md) | [(3.7) d](/filings/0001043000-26-000032.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [235](/filings/0001628280-23-009942.md) | [238](/filings/0001628280-23-009942.md) | [255](/filings/0001043000-25-000010.md) | [304](/filings/0001043000-26-000009.md) | [381](/filings/0001043000-26-000009.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | [22.7%](/filings/0001043000-25-000010.md) | [22.6%](/filings/0001043000-25-000010.md) | not reported | | Net margin | % | [53.5%](/filings/0001628280-23-009942.md) | [(22.8%)](/filings/0001628280-24-013376.md) | [(8.3%)](/filings/0001043000-25-000010.md) | [(0.7%)](/filings/0001043000-26-000009.md) | [(18.6%)](/filings/0001043000-26-000009.md) | | Diluted EPS | $ per share | [37.92](/filings/0001628280-23-009942.md) | [(9.27)](/filings/0001628280-24-013376.md) | [(3.85)](/filings/0001043000-25-000010.md) | [(0.54)](/filings/0001043000-26-000009.md) | [(4.22)](/filings/0001043000-26-000009.md) | | Free cash flow | $m | [(39.2)](/filings/0001628280-23-009942.md) | [(27.1)](/filings/0001628280-24-013376.md) | [(7.3)](/filings/0001043000-25-000010.md) | [(27.0)](/filings/0001043000-26-000009.md) | [(8.9)](/filings/0001043000-26-000009.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/snda/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Conversant Capital LLC](/funds/1850901.md) | 2026-06-30 | $595.9m | 14,605,874 | | Unchanged | | [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $134.3m | 3,291,753 | | Added +1,548,181 | | [Pertento Partners LLP](/funds/1894571.md) | 2026-06-30 | $96.9m | 2,375,656 | | New +2,375,656 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $90.5m | 2,218,503 | | Added +1,793,993 | | [Irenic Capital Management LP](/funds/1929389.md) | 2026-06-30 | $77.7m | 1,903,621 | | Added +683,874 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $52.6m | 1,289,010 | | Added +925,269 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $30.3m | 742,702 | | Added +582,872 | | [Tyro Capital Management LLC](/funds/1915395.md) | 2026-06-30 | $25.6m | 628,152 | | Added +591,701 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $25.2m | 618,498 | | Added +478,309 | | [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $23.3m | 571,641 | | Added +549,479 | ## Recent filings [All 1,189 filings](/companies/snda/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-07 | 21:04 ET | [8-K](/filings/0001193125-26-417059.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-417059 | | 2026-08-25 | 13:17 ET | [SCHEDULE 13D/A](/filings/0000895345-26-000375.md) | Ownership report, active investor, amended | 0000895345-26-000375 | | 2026-08-17 | 20:15 ET | [8-K](/filings/0001193125-26-354085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-354085 | | 2026-08-13 | 12:24 ET | [8-K](/filings/0001193125-26-347968.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-347968 | | 2026-08-10 | 01:33 ET | [SCHEDULE 13D/A](/filings/0000895345-26-000352.md) | Ownership report, active investor, amended | 0000895345-26-000352 | | 2026-08-10 | 21:16 ET | [8-K](/filings/0001193125-26-342676.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-342676 | | 2026-08-10 | 12:18 ET | [10-Q](/filings/0001043000-26-000032.md) | Quarterly report, period 2026-06-30 | 0001043000-26-000032 | | 2026-08-10 | 11:35 ET | [8-K](/filings/0001043000-26-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001043000-26-000030 | | 2026-06-12 | 13:06 ET | [8-K](/filings/0001193125-26-268586.md) | 5.07 Shareholder vote results | 0001193125-26-268586 | | 2026-06-01 | 12:09 ET | [8-K](/filings/0001193125-26-249799.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-249799 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001043000-26-000009.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1fee89db-0a6b-4ada-b8d5-91743c0b0c75) ## About the filer - CIK: 1043000 - Tickers: SNDA - Exchange: NYSE - SIC code: 8050 Services-Nursing & Personal Care Facilities - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.